Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,028.00
Bid: 12,026.00
Ask: 12,028.00
Change: -128.00 (-1.05%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,098.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Oil prices near 13-month highs, supported by Texas cold snap

Tue, 16th Feb 2021 11:32

* Brent, U.S. crude both near 13-month highs

* Texas cold snap shuts down oil wells and refineries

* Middle East supply worries raised due to Yemen conflict

* Norway secures wage deal in dispute at major oil terminal
(Updates prices, adds delay in U.S. inventory data)

By Shadia Nasralla

LONDON, Feb 16 (Reuters) - Oil prices hovered near 13-month
highs on Tuesday, supported by a cold snap that shut wells in
the biggest U.S. producing state Texas, although gains were
capped by a wage deal in Norway that averted supply disruptions
in Europe.

The global rollout of coronavirus vaccinations, fuelling
expectations of a recovery in the global economy and oil demand,
has also kept prices buoyant.

Keenly watched U.S. oil inventory data from the API industry
association and Energy Information Administration (EIA) will be
released this week on Wednesday and Thursday, respectively, each
delayed by a day after U.S. markets were closed on Monday.

Benchmark Brent crude slipped 16 cents, or 0.2%, to
$63.14 a barrel by 1056 GMT, but it remained to its highest
since January 2020 that was reached the previous session.

U.S. West Texas Intermediate (WTI) crude futures
gained 33 cents, or 0.6%, to $59.80 a barrel by 1056 GMT, after
touching their highest since early January 2020.

Cold weather in the United States halted operations at Texas
oil wells and refineries on Monday and forced restrictions on
natural gas and crude pipeline operators.

Texas produces about 4.6 million barrels per day of oil and
is home to 31 refineries, the most of any U.S. state and
including some of the country's largest, according to EIA data.

Middle East supply concerns also rose after the Saudi-led
coalition fighting the Houthi group in Yemen said on Monday it
had destroyed an explosive-laden drone fired by the Houthis at
the kingdom, the world's biggest oil exporter.

But in a move that helped cap prices, Norway's oil industry
employers struck a wage bargain with the Safe labour union on
Tuesday, preventing a strike at the Mongstad crude terminal that
could have forced major offshore oil and gas fields to shut.

(Additional reporting by Jessica Jaganathan in Singapore;
Editing by Edmund Blair)

More News
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.